Search results
Sandoz launches ustekinumab biosimilar in Europe
Pharmaceutical Technology· 18 hours agoUstekinumab targets IL-12 and IL-23, both interleukins, which are key to the pathogenesis of several inflammatory diseases. This inhibits signalling and...
‘Health product classification for standardisation, regulatory compliance, and effective healthcare...
Financial Express· 47 minutes agoThe conference also featured a dedicated session on the definition and categorization of health...
Drug giants eye China for deals despite growing Sino-US tensions
Hindustan Times· 3 days agoSome of the biggest global drugmakers, undeterred by mounting Sino-U.S. tensions, are scouring for...
